ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$195.16+0.14 (+0.07%)
Close on Nov 18, 2026Market cap $14.94BP/E 33.6Yield –
ICON operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
ICON's operating income for the twelve months ending Sep 30, 2026 was $718.25M, up 27.0% year over year. For fiscal 2025 it was $442.85M, down 57.1% from the year before. Over ten years it grew 4.6% a year on average. The highest annual figure on record is $1.03B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $442.85M | -57.1% |
| FY2024 | Dec 31, 2024 | $1.03B | +14.1% |
| FY2023 | Dec 31, 2023 | $904.66M | +13.8% |
| FY2022 | Dec 31, 2022 | $795.24M | +110.1% |
| FY2021 | Dec 31, 2021 | $378.53M | -3.3% |
| FY2020 | Dec 31, 2020 | $391.50M | -9.7% |
| FY2019 | Dec 31, 2019 | $433.41M | +16.1% |
| FY2018 | Dec 31, 2018 | $373.36M | +10.4% |
| FY2017 | Dec 31, 2017 | $338.34M | +8.5% |
| FY2016 | Dec 31, 2016 | $311.69M | +10.7% |
| FY2015 | Dec 31, 2015 | $281.54M | +39.1% |
| FY2014 | Dec 31, 2014 | $202.35M | +67.0% |
| FY2013 | Dec 31, 2013 | $121.17M | +78.1% |
| FY2012 | Dec 31, 2012 | $68.02M | +131.0% |
| FY2011 | Dec 31, 2011 | $29.44M | -68.0% |
| FY2010 | Dec 31, 2010 | $92.10M | -14.3% |
| FY2009 | Dec 31, 2009 | $107.45M | +8.0% |
| FY2008 | Dec 31, 2008 | $99.50M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $198.84M | – |
| Q2 FY2026 | Jun 30, 2026 | $137.83M | -40.3% |
| Q1 FY2026 | Mar 31, 2026 | $173.73M | -23.5% |
| Q4 FY2025 | Dec 31, 2025 | $207.85M | -37.1% |
| Q3 FY2025 | Sep 30, 2025 | -$222.91M | -173.7% |
| Q2 FY2025 | Jun 30, 2025 | $230.94M | +47.1% |
| Q1 FY2025 | Mar 31, 2025 | $226.97M | -6.4% |
| Q4 FY2024 | Dec 31, 2024 | $330.40M | +35.7% |
| Q3 FY2024 | Sep 30, 2024 | $302.57M | +19.6% |
| Q2 FY2024 | Jun 30, 2024 | $156.97M | -21.7% |
| Q1 FY2024 | Mar 31, 2024 | $242.45M | +16.8% |
| Q4 FY2023 | Dec 31, 2023 | $243.53M | +19.8% |
| Q3 FY2023 | Sep 30, 2023 | $252.92M | +3.8% |
| Q2 FY2023 | Jun 30, 2023 | $200.57M | +12.8% |
| Q1 FY2023 | Mar 31, 2023 | $207.64M | +21.9% |
| Q4 FY2022 | Dec 31, 2022 | $203.36M | +40.7% |
| Q3 FY2022 | Sep 30, 2022 | $243.74M | +4671.8% |
| Q2 FY2022 | Jun 30, 2022 | $177.79M | +57.5% |
| Q1 FY2022 | Mar 31, 2022 | $170.34M | +46.8% |
| Q4 FY2021 | Dec 31, 2021 | $144.54M | +20.6% |
| Q3 FY2021 | Sep 30, 2021 | $5.11M | -95.3% |
| Q2 FY2021 | Jun 30, 2021 | $112.87M | +98.2% |
| Q1 FY2021 | Mar 31, 2021 | $116.01M | +9.1% |
| Q4 FY2020 | Dec 31, 2020 | $119.86M | +3.9% |
| Q3 FY2020 | Sep 30, 2020 | $108.40M | -1.5% |
| Q2 FY2020 | Jun 30, 2020 | $56.95M | -46.3% |
| Q1 FY2020 | Mar 31, 2020 | $106.29M | +4.3% |
| Q4 FY2019 | Dec 31, 2019 | $115.33M | +13.3% |
| Q3 FY2019 | Sep 30, 2019 | $110.04M | +12.4% |
| Q2 FY2019 | Jun 30, 2019 | $106.09M | +29.5% |
| Q1 FY2019 | Mar 31, 2019 | $101.95M | +11.1% |
| Q4 FY2018 | Dec 31, 2018 | $101.79M | +13.4% |
| Q3 FY2018 | Sep 30, 2018 | $97.94M | +15.3% |
| Q2 FY2018 | Jun 30, 2018 | $81.91M | +5.0% |
| Q1 FY2018 | Mar 31, 2018 | $91.72M | +7.1% |
| Q4 FY2017 | Dec 31, 2017 | $89.74M | +6.0% |
| Q3 FY2017 | Sep 30, 2017 | $84.94M | – |
| Q2 FY2017 | Jun 30, 2017 | $78.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $85.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $84.64M | – |
See a number that looks wrong?